1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porters Fiver Forces Analysis 39
3 Segmentation of Global Market by Offering 43
3.1 Market Overview by Offering 43
3.2 Services 45
3.3 Test Kits & Consumables 46
4 Segmentation of Global Market by Application 47
4.1 Market Overview by Application 47
4.2 Non-Hodgkins Lymphoma (NHL) 49
4.2.1 DLBCL 51
4.2.2 Marginal Zone Lymphoma 52
4.2.3 Follicular Lymphoma 53
4.2.4 Peripheral T-cell Lymphoma 54
4.2.5 Mantle Cell Lymphoma 55
4.2.6 Other NHLs 56
4.3 Multiple Myeloma (MM) 57
4.4 Acute Lymphoblastic Leukemia (ALL) 58
4.5 Chronic Lymphoblastic Leukemia (CLL) 59
4.6 Acute Myeloid Leukemia (AML) 60
4.7 Chronic Myeloid Leukemia (CML) 61
4.8 Hodgkins Lymphoma (HL) 62
4.9 Solid Tumor 63
4.10 Other Applications 64
5 Segmentation of Global Market by Technology 65
5.1 Market Overview by Technology 65
5.2 Flow Cytometry 67
5.3 Polymerase Chain Reaction (PCR) 68
5.4 Next-Generation Sequencing (NGS) 69
5.5 Other Technologies 70
6 Segmentation of Global Market by End User 71
6.1 Market Overview by End User 71
6.2 Hospitals and Clinics 73
6.3 Research Institutions 74
6.4 Diagnostic Laboratories 75
6.5 Other End Users 76
7 Segmentation of Global Market by Region 77
7.1 Geographic Market Overview 2021-2031 77
7.2 North America Market 2021-2031 by Country 81
7.2.1 Overview of North America Market 81
7.2.2 U.S. 85
7.2.3 Canada 88
7.2.4 Mexico 90
7.3 European Market 2021-2031 by Country 92
7.3.1 Overview of European Market 92
7.3.2 Germany 96
7.3.3 U.K. 98
7.3.4 France 100
7.3.5 Spain 102
7.3.6 Italy 104
7.3.7 Netherlands 106
7.3.8 Rest of European Market 108
7.4 Asia-Pacific Market 2021-2031 by Country 110
7.4.1 Overview of Asia-Pacific Market 110
7.4.2 Japan 114
7.4.3 China 117
7.4.4 Australia 119
7.4.5 India 121
7.4.6 South Korea 123
7.4.7 Rest of APAC Region 125
7.5 South America Market 2021-2031 by Country 127
7.5.1 Argentina 130
7.5.2 Brazil 132
7.5.3 Chile 134
7.5.4 Rest of South America Market 136
7.6 MEA Market 2021-2031 by Country 137
7.6.1 UAE 140
7.6.2 Saudi Arabia 142
7.6.3 South Africa 144
7.6.4 Other National Markets 146
8 Competitive Landscape 147
8.1 Overview of Key Vendors 147
8.2 New Product Launch, Partnership, Investment, and M&A 151
8.3 Company Profiles 152
Adaptive Biotechnologies Corporation 152
ArcherDX, Inc. (Invitae Corporation) 154
Arup Laboratories 155
Asuragen Inc. 156
Bio-Rad Laboratories, Inc. 157
Cergentis B.V. 158
Guardant Health 159
ICON plc 160
Inivata Ltd. 161
Invivoscribe, Inc. 162
Laboratory Corporation of America Holdings 163
Mission Bio, Inc. 164
Natera, Inc. 165
NeoGenomics Laboratories, Inc. 166
Opko Health, Inc. 167
Quest Diagnostics Incorporated 168
Sysmex Corporation 169
RELATED REPORTS 170